Corporate Acquisitions

CVS says it standing by its offer for Longs

CVS says it not changing its $2.7B offer for Longs despite rival bid from Walgreen

CVS Caremark says it is leaving its $2.7 billion bid for Longs Drug Stores unchanged, despite it being topped by rival Walgreen.

Woonsocket-based CVS said Sunday it was extending its $71.50-per-share tender offer for Longs until Oct. 15. The tender was due to expire on Monday.

"All other terms and conditions of the tender offer remain unchanged," CVS said in a statement.

On Friday, Deerfield, Ill.-based Walgreen Co. offered to buy Longs for $75 a share, or about $2.8 billion, hoping to unseat the offer from CVS, which Longs has already accepted.

Walnut Creek, Calif-based Longs said Sunday it was reviewing Walgreen's offer "terms of its existing merger agreement with CVS Caremark."

AP News |